MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration

Life Sci. 2006 Sep 20;79(17):1657-60. doi: 10.1016/j.lfs.2006.05.024. Epub 2006 Jun 2.

Abstract

We have previously shown that matrix metalloproteinases (MMPs) play a role in osteoclastic bone resorption by facilitating migration of osteoclastic cells toward bone surface through matrices. Of MMPs identified so far, MMP-9 is likely the most important proteinase for the action, since osteoclasts express this enzyme at a tremendously high level. However, no direct evidence has been provided to demonstrate its contribution to bone resorption. In this study, to address this point, we used an MMP-9 antisense phosphothiorate oligodeoxynucleotide (S-ODN), which was shown to inhibit the protein synthesis of MMP-9 efficiently. We demonstrated that the antisense S-ODN inhibited osteoclastic pit formation on matrigel-coated dentine slices in a concentration-dependent manner with a maximum reduction of total pit volume by 53% at 10 microM. These results, taken together, suggest that MMP-9 is involved in osteoclastic bone resorption process possibly by facilitating migration of osteoclasts through proteoglican-rich matrices.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Bone Resorption / enzymology*
  • Bone Resorption / prevention & control
  • Cell Movement / drug effects*
  • Cells, Cultured
  • Dose-Response Relationship, Drug
  • Matrix Metalloproteinase 9 / biosynthesis
  • Matrix Metalloproteinase 9 / genetics*
  • Oligodeoxyribonucleotides, Antisense / pharmacology*
  • Osteoclasts / drug effects*
  • Rabbits

Substances

  • Oligodeoxyribonucleotides, Antisense
  • Matrix Metalloproteinase 9